Bernard J. Zovighian's most recent trade in Edwards Lifesciences Corp was a trade of 16,099 Common Stock done at an average price of $77.2 . Disclosure was reported to the exchange on May 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Sale of securities on an exchange or to another person at price $ 77.21 per share. | 30 May 2025 | 16,099 | 9,563 (0%) | 0% | 77.2 | 1,243,065 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Sale of securities on an exchange or to another person at price $ 77.32 per share. | 30 May 2025 | 967 | 8,596 (0%) | 0% | 77.3 | 74,772 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 16 May 2025 | 5,815 | 80,976 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 16 May 2025 | 5,815 | 25,662 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.68 per share. | 11 May 2025 | 2,860 | 89,562 (0%) | 0% | 73.7 | 210,725 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2025 | 2,771 | 19,847 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 May 2025 | 2,771 | 86,791 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 244,400 | 244,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 43,550 | 43,550 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 43,550 | 96,544 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.92 per share. | 07 May 2025 | 4,253 | 52,994 (0%) | 0% | 74.9 | 318,635 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2025 | 4,122 | 17,076 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2025 | 4,122 | 92,422 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2025 | 7,462 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 03 May 2025 | 7,462 | 65,745 (0%) | 0% | 45.3 | 337,855 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Sale of securities on an exchange or to another person at price $ 74.91 per share. | 03 May 2025 | 5,980 | 58,283 (0%) | 0% | 74.9 | 447,977 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 May 2025 | 1,482 | 11,918 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 May 2025 | 1,482 | 64,263 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 May 2025 | 1,036 | 12,954 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 May 2025 | 1,036 | 57,247 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.65 per share. | 03 May 2025 | 543 | 58,283 (0%) | 0% | 75.7 | 41,078 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.65 per share. | 03 May 2025 | 527 | 58,826 (0%) | 0% | 75.7 | 39,868 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.28 per share. | 10 Mar 2025 | 7,463 | 66,545 (0%) | 0% | 45.3 | 337,900 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 7,463 | 7,462 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Sale of securities on an exchange or to another person at price $ 69.51 per share. | 10 Mar 2025 | 6,164 | 59,082 (0%) | 0% | 69.5 | 428,448 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Mar 2025 | 1,299 | 10,436 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Mar 2025 | 1,299 | 65,246 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Sale of securities on an exchange or to another person at price $ 87.68 per share. | 30 May 2024 | 8,617 | 68,217 (0%) | 0% | 87.7 | 755,539 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 11 May 2024 | 2,854 | 76,834 (0%) | 0% | 86.7 | 247,499 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 178,400 | 178,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 33,500 | 80,335 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 33,500 | 33,500 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 647 | 79,688 (0%) | 0% | 85.1 | 55,053 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 6,265 | 0 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 6,265 | 50,553 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 3,718 | 46,835 (0%) | 0% | 85.3 | 316,960 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Purchase of securities on an exchange or from another person at price $ 85.78 per share. | 03 May 2024 | 580 | 3,267 (0%) | 0% | 85.8 | 49,753 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 527 | 44,288 (0%) | 0% | 85.1 | 44,827 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | Director, CEO | 31 Jul 2023 | 2,558 | 47,111 (0%) | 0% | 83.6 | 213,744 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 173,700 | 173,700 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 28,150 | 28,150 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 22,525 | 44,552 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 5,003 | 25,783 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 5,003 | 1,372 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 2,323 | 23,460 (0%) | 0% | 88.7 | 206,143 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 1,433 | 22,027 (0%) | 0% | 88.7 | 127,164 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.10 per share. | 03 May 2023 | 370 | 20,780 (0%) | 0% | 88.1 | 32,597 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.81 per share. | 03 May 2023 | 359 | 21,150 (0%) | 0% | 87.8 | 31,524 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 103.66 per share. | 05 Aug 2022 | 4,811 | 21,246 (0%) | 0% | 103.7 | 498,708 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 87.75 per share. | 14 Jun 2022 | 4,809 | 26,007 (0%) | 0% | 87.8 | 421,990 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 100.83 per share. | 31 May 2022 | 9,000 | 30,816 (0%) | 0% | 100.8 | 907,489 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Sale of securities on an exchange or to another person at price $ 95.52 per share. | 24 May 2022 | 4,809 | 39,816 (0%) | 0% | 95.5 | 459,356 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.93 per share. | 17 May 2022 | 1,711 | 44,625 (0%) | 0% | 95.9 | 164,136 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2022 | 12,600 | 0 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2022 | 12,600 | 53,173 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.52 per share. | 07 May 2022 | 6,837 | 46,336 (0%) | 0% | 100.5 | 687,255 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.52 per share. | 07 May 2022 | 633 | 40,573 (0%) | 0% | 100.5 | 63,629 | Common Stock |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 33,700 | 33,700 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 5,200 | 5,200 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 4,150 | 41,576 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Bernard J. Zovighian | CVP, TMTT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.93 per share. | 03 May 2022 | 370 | 41,206 (0%) | 0% | 105.9 | 39,194 | Common Stock |